🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 4 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/01/2012 | 49,73 | 49,73 | 48,31 | 48,38 | -1,79% | 2,86% | 981.300 |
| 20/01/2012 | 48,47 | 49,34 | 48,26 | 49,26 | +1,69% | 2,23% | 998.100 |
| 19/01/2012 | 48,69 | 48,76 | 47,98 | 48,44 | +0,31% | 1,60% | 696.900 |
| 18/01/2012 | 47,61 | 48,55 | 47,29 | 48,29 | +1,96% | 2,65% | 1.096.600 |
| 17/01/2012 | 47,56 | 47,67 | 47,01 | 47,36 | +0,74% | 1,39% | 560.100 |
| 13/01/2012 | 47,53 | 47,95 | 46,09 | 47,01 | -1,98% | 3,91% | 1.592.900 |
| 12/01/2012 | 48,41 | 48,66 | 47,88 | 47,96 | -0,54% | 1,61% | 1.034.500 |
| 11/01/2012 | 48,48 | 48,81 | 47,85 | 48,22 | -1,11% | 1,98% | 1.052.400 |
| 10/01/2012 | 48,79 | 49,17 | 48,42 | 48,76 | +1,29% | 1,54% | 744.400 |
| 09/01/2012 | 48,93 | 49,57 | 47,90 | 48,14 | -0,78% | 3,41% | 1.152.700 |
| 06/01/2012 | 48,03 | 49,22 | 48,02 | 48,52 | +0,89% | 2,50% | 1.066.000 |
| 05/01/2012 | 47,50 | 48,56 | 47,50 | 48,09 | +0,84% | 2,23% | 641.300 |
| 04/01/2012 | 47,74 | 48,05 | 47,54 | 47,69 | -0,27% | 1,07% | 761.000 |
| 03/01/2012 | 47,81 | 48,65 | 47,53 | 47,82 | +1,21% | 2,34% | 992.600 |
| 30/12/2011 | 47,42 | 48,09 | 46,84 | 47,25 | -0,61% | 2,64% | 563.500 |
| 29/12/2011 | 46,16 | 47,62 | 46,03 | 47,54 | +3,19% | 3,44% | 718.600 |
| 28/12/2011 | 47,05 | 47,05 | 46,06 | 46,07 | -1,98% | 2,10% | 810.400 |
| 27/12/2011 | 46,66 | 47,06 | 46,09 | 47,00 | +0,95% | 2,08% | 789.000 |
| 23/12/2011 | 46,01 | 46,67 | 45,53 | 46,56 | +0,82% | 2,48% | 521.600 |
| 22/12/2011 | 45,04 | 46,23 | 44,81 | 46,18 | +2,69% | 3,15% | 952.200 |
| 21/12/2011 | 44,89 | 45,32 | 44,11 | 44,97 | +1,01% | 2,70% | 1.210.900 |
| 20/12/2011 | 43,52 | 44,59 | 43,52 | 44,52 | +3,80% | 2,46% | 1.267.200 |
| 19/12/2011 | 43,53 | 44,25 | 42,83 | 42,89 | -0,81% | 3,26% | 1.421.800 |
| 16/12/2011 | 42,12 | 43,38 | 42,02 | 43,24 | +3,08% | 3,23% | 1.403.500 |
| 15/12/2011 | 41,26 | 42,35 | 41,17 | 41,95 | +2,47% | 2,86% | 1.015.700 |
| 14/12/2011 | 41,42 | 41,61 | 40,63 | 40,94 | -1,75% | 2,37% | 1.170.000 |
| 13/12/2011 | 42,06 | 42,43 | 41,14 | 41,67 | -0,07% | 3,07% | 1.499.300 |
| 12/12/2011 | 41,67 | 42,20 | 41,19 | 41,70 | -0,76% | 2,42% | 2.478.700 |
| 09/12/2011 | 41,33 | 42,68 | 40,98 | 42,02 | +2,09% | 4,11% | 788.900 |
| 08/12/2011 | 41,57 | 41,92 | 41,11 | 41,16 | -1,81% | 1,95% | 769.700 |